- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Statin discontinuation in persons with and without Alzheimer’s disease ; volume:78 ; number:7 ; day:21 ; month:4 ; year:2022 ; pages:1145-1153 ; date:7.2022
European journal of clinical pharmacology ; 78, Heft 7 (21.4.2022), 1145-1153, 7.2022
- Creator
-
Vu, Mai
Kettunen, Raimo
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Taipale, Heidi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-022-03320-3
- URN
-
urn:nbn:de:101:1-2022080606582329357330
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vu, Mai
- Kettunen, Raimo
- Tolppanen, Anna-Maija
- Hartikainen, Sirpa
- Taipale, Heidi
- SpringerLink (Online service)
Other Objects (12)
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Psychosis in Alzheimer’s Disease
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease